Clinical Trial Update: Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating a three-drug regimen of laromustine, daunorubicin, and cytarabine in acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Laromustine (laromustine)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED